Primary Care POC Diagnostics Market Report 2026

Primary Care POC Diagnostics Market Overview

• Primary Care POC Diagnostics market size has reached to $17.38 billion in 2025 • Expected to grow to $24.6 billion in 2030 at a compound annual growth rate (CAGR) of 7.3% • Growth Driver: Driving Forces Behind The Growth Of Primary Care Point-Of-Care Diagnostics Market • Market Trend: Advancing Rapid Diagnostic Innovation for Primary Care Settings • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Primary Care POC Diagnostics Market?

A primary care point-of-care (POC) diagnostic is a medical test or assessment performed conveniently and quickly within a primary care setting, such as a doctor's office or a clinic, without requiring specialized equipment or extensive laboratory processing. These diagnostics are designed to provide rapid results, allowing healthcare providers to make timely decisions about patient care during the initial consultation. The main products of primary care POC diagnostics are glucose monitoring, cardiometabolic testing products, infectious disease testing products, coagulation testing products, pregnancy and fertility testing products, tumor or cancer marker testing products, cholesterol testing products, hematology testing products, drug-of-abuse (DOA) testing products, and others. Glucose monitoring refers to the process of measuring blood glucose levels to manage diabetes. These are based on prescription types such as prescription-based and over-the-counter (OTC) testing and used in various end uses, including hospitals, diagnostic centers, research laboratories, home-care settings, and others.

What Is The Primary Care POC Diagnostics Market Growth Forecast?

The primary care poc diagnostics market size is expected to see strong growth in the next few years. It will grow to $24.6 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing demand for decentralized diagnostics, rising integration of ai-enabled diagnostics, expansion of telehealth-supported testing, growing focus on preventive screening, increasing investments in personalized diagnostics. Major trends in the forecast period include increasing adoption of rapid diagnostic testing, growing integration of digital poc devices, rising demand for home-use diagnostic kits, expansion of multiplex testing platforms, enhanced focus on early disease detection.

Global Primary Care POC Diagnostics Market Segmentation

1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products 2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing 3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses Subsegments: 1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions 2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices 3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests 4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors 5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices 6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits 7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices 8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices 9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests 10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices

What Is The Driver Of The Primary Care POC Diagnostics Market?

The rise in the prevalence of infectious diseases is expected to propel the growth of the primary care POC diagnostics market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. These diseases spread from one person to another directly or indirectly through contact with contaminated surfaces, air, water, or vectors such as insects. The prevalence of infectious diseases is due to poor environmental conditions, urbanization, antimicrobial resistance, and inadequate vaccination coverage. Primary care POC diagnostics are integral tools for combating the prevalence of infectious diseases by facilitating early detection, timely treatment, and effective disease control measures in diverse healthcare settings. For instance, in March 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, tuberculosis cases rose from 9,622 in 2023 to 10,347 in 2024 (an 8% increase), with the incidence rate increasing from 2.9 to 3.0 per 100,000 population (a 6% rise). Therefore, the rise in the prevalence of infectious diseases is driving the primary care POC diagnostics industry.

Key Players In The Global Primary Care POC Diagnostics Market

Major companies operating in the primary care poc diagnostics market are Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

Global Primary Care POC Diagnostics Market Trends and Insights

Major companies operating in the primary care POC diagnostics market are focusing on developing advanced microfluidic-based rapid susceptibility testing to enhance timely antibiotic decision-making. Microfluidic rapid susceptibility testing uses tiny fluid channels to isolate and grow bacteria quickly, enabling early identification of how they respond to different antimicrobials and reducing waiting time for results. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostic solutions company, launched the PA-100 AST System featuring proprietary microfluidic technology. This system can detect bacteria from urine samples in about 15 minutes and deliver antimicrobial susceptibility test (AST) results in as little as 30 minutes at the initial clinic visit. The analyzer is compact, desktop-sized, and works with reagent cartridges into which samples are directly placed for automatic measurement. Healthcare professionals without specialized lab training can operate it easily. By speeding up diagnostics, the device supports appropriate antimicrobial use during first patient visits and helps in the global fight against antimicrobial resistance.

What Are Latest Mergers And Acquisitions In The Primary Care POC Diagnostics Market?

In July 2024, F. Hoffmann-La Roche Ltd., a Switzerland-based pharmaceutical company, acquired LumiraDx's point-of-care technology form LumiraDx for 350 million. With this acquisition, Roche aims to expand its diagnostic portfolio and improve access to decentralized testing, particularly in primary care settings and low- to middle-income countries. LumiraDx is a UK-based, point-of-care diagnostic company that focuses on transforming community-based healthcare.

Regional Outlook

North America was the largest region in the primary care POC diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Primary Care POC Diagnostics Market?

The primary care POC diagnostics market consists of sales of respiratory pathogen testing products, thyroid function testing products, electrolyte testing products, and liver function testing products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Primary Care POC Diagnostics Market Report 2026?

The primary care poc diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the primary care poc diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.